Catecholamines in plasma
Material: | 4 ml EDTA-plasma, divide plasma as soon as possible (Stability in plasma at4°C – 8°C: 2 days). In case of longer storage or postal shipping, please freeze plasma. The evaluation of metanephrine and normetanephrine in plasma can be used for screening of pheochromocytomas/paragangliomas. To avoid false-positive results, blood extraction should be done in an empty-stomached patient after resting in supine position for 20 – 30 minutes, via a previously inserted venous catheter. Due to the uniform use of frozen EDTA-plasma, glutathione tubes are no longer required. 2 – 3 days before the test, coffee, tea, nicotine, alcohol, chocolate, banana, eggs and nuts should be avoided. As far as reasonable, all medication should be discontinued 7 – 14 days prior to test. Theophylline, MAO-inhibitors, phenothiazine, methyldopa, and levodopa can be responsible for an increased catecholamine release for up to 2 weeks and should definitely be discontinued. Diuretics, alpha- and beta-receptor blockers, vasodilators, calcium-antagonists, angiotensin-II-antagonists and ACE-inhibitors, Clonidine (Catapressan®) should also be discontinued where possible. A strong sympathicus stimulation through hypoglycemia, physical exertion or increased intracranial pressure can also lead to increased catecholamine release. |
Methods: | Hochleistungsflüssigkeitschromatographie (HPLC) → Hochleistungsflüssigkeitschromatographie (HPLC) | Reference range | Adrenalin Noradrenalin Dopamine |
Indication | Suspicion of secondary hypertension, diagnosis and progress checks of pheochromocytoma or pheochromocytoma-paraganglioma-syndrome, screening in case of MEN 2A, neurofibromatosis type 1, Hippel-Lindau syndrome and Incidentaloma. Neuroblastomas (in connection to vanillic acid and homovanillylmandelic acid), ganglioneuroma |
Please note | It has to be mentioned, that missing catecholamine release does not rule out pheochromocytoma/paraganglioma, as there are asecretory variants, which appear especially at a higher age. Furthermore, dopamine production should be considered in clinically unapparent pheochromocytomas/paragangliomas, hence dopamine or its degradation product 3-methoxytyramine (only in plasma) should be determined. |
Accredited | ja |
More Results for the letter C
- C-peptide in the serum (CPEP)
- C1-esterase inhibitor (C1-INH) (C1EA, C1EH)
- Activity evaluation, protein evaluation
- C2-complement (C2S)
- C3-complement in the serum (C3)
- C3-nephritis factor (C3NF)
- C3NeF
- C4-complement in the serum (C4)
- CA 125 (CA 125)
- CA 15-3 (CA15)
- CA 19-9 (CA19)
- CA 72-4 (CA72)
- Cadmium (CAD)
- Cd
- Caeruloplasmin (α2-) (CAER(a2))
- Caffeine (COFF)
- Calcitonin (CALC)
- hCT, human calcitonin
- Calcium in serum (CA)
- Ca
- Calcium in urine (CAU)
- Calcium, ionized, in serum (CAI)
- Calprotectin (ECALP)
- Calymmatobacterium granulomatis (CALY)
- Donovaniosis
- Campylobacter jejuni/coli infection (KCAMP, ECAMP, CAMPG, CAMPA)
- Canary serum, feather, excrement antibodies (IgG) (CANA)
- Candida infection (KCAND)
- Cannabinoids (CANN)
- Tetrahydrocannabinol, delta-9 THC, cannabis, weed, marihuana, hash
- Carbamazepine (CARB)
- Carboxyhemoglobin (COHB)
- CO-Hb
- Cardiac muscle antibodies (HMA)
- Carnitine ratio: Acyl carnitine / free carnitine (CARNF)
- Carotene (β-) (CARO(b))
- Group of carotenoids with provitamine A activity
- Cartilage autoantibodies (KNOR)
- Catecholamines in plasma (KATP)